1. Tissue Repair & Recovery
BPC-157 (Body Protection Compound-157)
- Description: A synthetic peptide derived from a protective protein in human gastric juice. It accelerates tendon, ligament, joint, and gut tissue repair by promoting angiogenesis (new blood vessel formation) and modulating local inflammation.
- Dosage Range: 250 mcg to 500 mcg per day, administered subcutaneously near the target site or systematically.
- Cycle Duration: 4 to 8 weeks, followed by a minimum 4-week washout period.
TB-500 (Thymosin Beta-4 Fragment)
- Description: A synthetic fragment of Thymosin Beta-4 that regulates cell migration and actin polymerization. It enhances wound healing, tissue flexibility, and repair in cardiac and skeletal muscle.
- Dosage Range: 2 mg to 5 mg per week, often split into two equal subcutaneous doses.
- Cycle Duration: 6 to 10 weeks, followed by a 4-to-6-week break.
2. Metabolic & Weight Management
Retatrutide (Triple G Agonist)
- Description: A novel, next-generation peptide that acts as a triple agonist targeting GLP-1, GIP, and Glucagon receptors. By simultaneously targeting all three receptors, it dramatically accelerates lipid metabolism, increases energy expenditure, and suppresses appetite while supporting glycemic control.
- Dosage Range: Titrated slowly starting from 1.0–2.0 mg per week, increasing gradually over several weeks to a target research range of 4.0–12.0 mg per week administered subcutaneously.
- Cycle Duration: Structured 12-to-24-week metabolic protocols, monitored with step-wise dose titration.
Tirzepatide & Semaglutide (Dual/Single Incretin Agonists)
- Description: Advanced incretin-mimetic peptides designed to regulate blood sugar, delay gastric emptying, and suppress appetite via central satiety pathways to optimize body composition.
- Dosage Range:
- Semaglutide: Titrated from 0.25 mg/week up to 1.7–2.4 mg/week.
- Tirzepatide: Titrated from 2.5 mg/week up to 5–15 mg/week.
- Cycle Duration: Continuous management or structured 12-to-24-week metabolic cycles.
Tesamorelin
- Description: A potent Growth Hormone-Releasing Hormone (GHRH) analog specifically designed to target visceral adipose tissue (deep abdominal fat) while preserving lean muscle tissue.
- Dosage Range: 1 mg to 2 mg daily via subcutaneous injection on an empty stomach or prior to sleep.
- Cycle Duration: 12 to 16 weeks on, followed by a 4-to-8-week off-cycle.
3. Growth Hormone & Muscle Optimization
CJC-1295 (No DAC) + Ipamorelin
- Description: A synergistic combination pairing CJC-1295 (a GHRH analog) with Ipamorelin (a selective ghrelin/GH secretagogue agonist). Together, they stimulate natural, pulsatile growth hormone release without raising cortisol or prolactin levels.
- Dosage Range: 100 mcg CJC-1295 combined with 100–200 mcg Ipamorelin per injection, taken 1–2 times daily while fasted.
- Cycle Duration: 12 to 16 weeks on-cycle, followed by a 4-to-8-week break (frequently run on a 5 days on, 2 days off weekly routine).
4. Cellular Longevity & Energetics
SS-31 (Elamipretide)
- Description: A mitochondria-targeted tetrapeptide that selectively concentrates in the inner mitochondrial membrane, binding directly to cardiolipin. It restores mitochondrial structure, prevents electron leakage, reduces reactive oxygen species (ROS), and maximizes ATP generation under metabolic stress or physical exertion.
- Dosage Range: 10 mg to 40 mg daily, administered subcutaneously.
- Cycle Duration: 4 to 8 weeks during high-intensity stress or recovery cycles, followed by a 4-week break.
MOTS-c
- Description: A mitochondria-derived peptide that activates AMP-activated protein kinase (AMPK)—the body's master metabolic switch. It enhances cellular energy, improves glucose disposal, and increases physical endurance.
- Dosage Range: 5 mg to 10 mg administered 1 to 3 times per week subcutaneously.
- Cycle Duration: 4 to 6 weeks during high physical demands, followed by a 4-week rest period.
GHK-Cu (Copper Peptide)
- Description: A naturally occurring tripeptide coupled with copper that upregulates collagen gene expression, accelerates tissue repair, and supports skin elasticity, hair follicle vitality, and overall cellular integrity.
- Dosage Range: 1 mg to 2 mg daily subcutaneously, or applied topically via specialized formulations.
- Cycle Duration: 6 to 8 weeks on, followed by a 4-week break.
General Cycling & Safety Best Practices
- Receptor Sensitization: Utilizing structured off-cycles (4–8 weeks off following active cycles) prevents receptor desensitization and maintains compound efficacy.
- Fasted Administration: Growth hormone secretagogues should be administered on an empty stomach (at least 2 hours post-meal or prior to sleep) to prevent elevated insulin/glucose from blunting GH release.
- Storage & Stability: Reconstituted peptides must be preserved with bacteriostatic water and stored in refrigeration between 2°C and 8°C (36°F–46°F) away from direct light.
⚠️ Regulatory & Educational Disclaimer
For Educational & Research Reference Only. The protocols and ranges outlined above reflect common research parameters. These statements have not been evaluated by the Food and Drug Administration (FDA). Always consult a licensed healthcare professional before engaging in peptide administration.